Literature DB >> 7791978

Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients.

E Gay1, L N Sekhar, E Rubinstein, D C Wright, C Sen, I P Janecka, C H Snyderman.   

Abstract

The management of chordomas and chondrosarcomas involving the cranial base remains controversial. The options for therapy include biopsy, partial resection, radical resection, and various forms of radiotherapy. In this article, we analyze the outcome of 60 patients with cranial base chordoma or chondrosarcoma treated with extensive surgical resection between 1984 and 1993. Forty-six patients had chordomas, and 14 had low-grade chondrosarcomas; 50% of these patients had been treated previously. Preoperative studies included computed tomography, magnetic resonance imaging, cerebral angiography, and balloon occlusion test of the internal carotid artery, as indicated. Magnetic resonance imaging was performed on all patients during follow-up. The surgical approaches used for tumor resection were predominantly the following: subtemporal, transzygomatic, transcavernous, and transpetrous apex; subtemporal and infratemporal; extended frontal; and extreme lateral transcondylar. Staged operations with a combination of approaches were used when necessary (52% of cases) to remove a tumor more completely. Statistical analysis was done by the chi 2 test and correlation matrix. Sixty-seven percent of the patients had total or near-total resection. Twenty percent of the patients received postoperative radiotherapy. Eleven patients died during the postoperative follow-up period, nine with chordomas and two with chondrosarcomas. Three patients died because of systemic complications within 3 months after surgery, five died because of tumor recurrence, one died from unrelated causes, and two died from late complications of radiotherapy. The recurrence-free survival rate for all tumors was 80% at 3 years and 76% at 5 years. Chondrosarcomas had a better prognosis than chordomas (recurrence-free survival rates, 90% at 5 years and 65% at 5 years, respectively; P = 0.09). Patients who had undergone previous surgery had a greater risk of recurrence (5-year recurrence-free survival rate, 64%) than did patients who had not undergone previous surgery (5-year recurrence-free survival rate, 93%; P < 0.05). Patients with total or near-total resection had a better 5-year recurrence-free survival rate (84%) than did patients with partial or subtotal resection (64%) (P < 0.05). Postoperative leakage of cerebrospinal fluid was the most frequent complication (30% of patients) and was found to increase the risk of permanent disability. Patients who had undergone previous radiotherapy had a greater risk of death in the postoperative period (within 3 months of their operations) and during follow-up. However, total or near-total resection did not increase the rate of postoperative disability.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7791978     DOI: 10.1227/00006123-199505000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  86 in total

1.  Recurrent chondrosarcoma of the cranial base: a durable response to ifosfamide-doxorubicin chemotherapy.

Authors:  R V La Rocca; K W Morgan; K Paris; T R Baeker
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

2.  Classification and surgical approaches for transnasal endoscopic skull base chordoma resection: a 6-year experience with 161 cases.

Authors:  Songbai Gui; Xuyi Zong; Xinsheng Wang; Chuzhong Li; Peng Zhao; Lei Cao; Yazhuo Zhang
Journal:  Neurosurg Rev       Date:  2016-02-03       Impact factor: 3.042

Review 3.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

4.  Endoscopic and Microscopic Extended Subfrontal Approach to the Clivus: A Comparative Anatomical Study.

Authors:  Pietro Mortini; Fabio Roberti; Chandrasekar Kalavakonda; Amal Nadel; Laligam N Sekhar
Journal:  Skull Base       Date:  2003-08

5.  Corridor surgery: the current paradigm for skull base surgery.

Authors:  Stephen M Pirris; Ian F Pollack; Carl H Snyderman; Ricardo L Carrau; Richard M Spiro; Elizabeth Tyler-Kabara; Amin B Kassam
Journal:  Childs Nerv Syst       Date:  2007-01-17       Impact factor: 1.475

6.  Carbon-11-methionine positron emission tomography imaging of chordoma.

Authors:  Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Kenji Sagou; Mei Tian; Tetsuya Suhara; Susumu Kandatsu; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Journal:  Skeletal Radiol       Date:  2004-07-28       Impact factor: 2.199

7.  Surgical management of petroclival chordomas: report of eight cases.

Authors:  Toshihiro Takami; Kenji Ohata; Takeo Goto; Naohiro Tsuyuguchi; Akimasa Nishio; Mitsuhiro Hara
Journal:  Skull Base       Date:  2006-05

8.  Surgical treatment of skull base chondrosarcomas.

Authors:  Amir Samii; Venelin Gerganov; Christian Herold; Alireza Gharabaghi; Nakamasa Hayashi; Madjid Samii
Journal:  Neurosurg Rev       Date:  2008-09-26       Impact factor: 3.042

Review 9.  Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.

Authors:  Brian J Jian; Orin G Bloch; Isaac Yang; Seunggu J Han; Derick Aranda; Tarik Tihan; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-12-02       Impact factor: 4.130

10.  Bilateral chondrosarcoma of the jugular foramen: literature review and personal experience.

Authors:  Elisabetta Zanoletti; Chiara Faccioli; Diego Cazzador; Antonio Mazzoni; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.